AKT1 and non-small cell lung carcinoma: NSCLC patients with low expression of G3BP1 (Figure 4A, P = .007), YB1 (Figure 4B, P = .025) and p‐AKT protein (Figure 4C, P = .037) survived longer than those with high expression.